{"id":17475,"date":"2025-05-22T15:56:22","date_gmt":"2025-05-22T15:56:22","guid":{"rendered":"https:\/\/www.drfz.de\/?p=17475"},"modified":"2025-07-21T07:46:47","modified_gmt":"2025-07-21T07:46:47","slug":"early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research","status":"publish","type":"post","link":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/","title":{"rendered":"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research"},"content":{"rendered":"\n
\"The
Participants in the Cluster of Excellence ImmunoPreCept celebrate the project’s approval at the DRFZ on 22 June 2025.<\/figcaption><\/figure>\n\n\n\n

The DRFZ is part of the new Cluster of Excellence<\/h2>\n\n\n\n

The German Rheumatology Research Center, a Leibniz Institute, is partner in the new Berlin Cluster of Excellence ImmunoPreCept. Together with Charit\u00e9, the Max Delbr\u00fcck Center for Molecular Medicine (MDC), Humboldt University, Freie Universit\u00e4t Berlin and other partners, the DRFZ is researching the transition from health to disease – with the aim to launch a new era of cell-based prevention and early medical intervention.<\/p>\n\n\n\n

The focus will be on the immune system, not as a trigger of disease, but as a central player in maintaining health. Malfunctions of immunological processes are often the starting point of chronic inflammatory diseases such as rheumatoid arthritis, Crohn’s disease or certain forms of cancer. State-of-the-art single cell analysis, functional immune profiling and AI-driven methods will be used to identify early molecular signatures that enable targeted medical intervention – before clinical symptoms appear. This approach of ‘interceptive’ medicine represents a paradigm shift in healthcare.<\/p>\n\n\n\n

With decades of successful research in inflammatory systemic diseases, the DRFZ contributes its expertise in functional immune analysis and translational research to the cluster, particularly at the interface between basic research, clinical application and individual prevention.<\/p>\n\n\n\n

In addition to research, a focus is put on increased dialogue with the public. In collaboration with the Museum f\u00fcr Naturkunde Berlin, the public will be actively involved – with the aim of sustainably anchoring this innovative research approach in healthcare.<\/p>\n\n\n\n

\n
Press release by Charit\u00e9<\/a><\/div>\n<\/div>\n\n\n\n

PIs at DRFZ<\/h2>\n\n\n\n
\n
\n \n
\n \n\n
\n \"\" <\/div>\n
\n

Prof. Dr. Andreas Diefenbach<\/h2>\n
\n

\n Programme Area 1, PA 1 \u2013 Cell and Tissue Rheumatology <\/p>\n

\n Group leader: Developmental and Mucosal Immunology <\/p>\n Liaison working group with Charit\u00e9 – Microbiology, Infectious Diseases and Immunology,<\/p>\n <\/div>\n <\/div>\n\n

\n

andreas.diefenbach@charite.de<\/a><\/p>\n <\/div>\n Prof. Dr. Andreas Diefenbach<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Prof. Dr. med. Dr. rer. nat. Ahmed N. Hegazy<\/h2>\n
\n

\n Programme Area 4, PA 4 \u2013 Translational Rheumatology <\/p>\n

\n Group leader: Inflammatory Mechanisms <\/p>\n Liaison working group with Charit\u00e9 – Gastroenterology, Infectiology and Rheumatology<\/p>\n <\/div>\n <\/div>\n\n

\n

ahmed.hegazy@charite.de<\/a><\/p>\n <\/div>\n Prof. Dr. med. Dr. rer. nat. Ahmed N. Hegazy<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Prof. Dr. Gerhard Kr\u00f6nke<\/h2>\n
\n

\n Programme Area 4, PA 4 \u2013 Translational Rheumatology <\/p>\n Liaison working group with Charit\u00e9 – Rheumatology and Clinical Immunology<\/p>\n <\/div>\n <\/div>\n\n

\n

gerhard.kroenke@charite.de<\/a><\/p>\n <\/div>\n Prof. Dr. Gerhard Kr\u00f6nke<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Prof. Dr. med. Eicke Latz<\/h2>\n
\n

Scientific Director<\/p>\n

\n Programme Area 1, Directors <\/p>\n

\n Group leader: Immunobiology of inflammation <\/p>\n <\/div>\n <\/div>\n\n

\n

eicke.latz@drfz.de<\/a><\/p>\n <\/div>\n Prof. Dr. med. Eicke Latz<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Prof. Dr. Chiara Romagnani<\/h2>\n
\n

\n Programme Area 1, PA 1 \u2013 Cell and Tissue Rheumatology <\/p>\n

\n Group leader: Innate Immunity <\/p>\n Liaison working group with Charit\u00e9 – Institute of Medical Immunology<\/p>\n <\/div>\n <\/div>\n\n

\n

romagnani@drfz.de<\/a><\/p>\n <\/div>\n Prof. Dr. Chiara Romagnani<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Prof. Antigoni Triantafyllopoulou, MD<\/h2>\n
\n

\n Programme Area 1, PA 1 \u2013 Cell and Tissue Rheumatology <\/p>\n

\n Group leader: Macrophage biology and innate cellular networks in chronic inflammatory diseases <\/p>\n Liaison working group with Charit\u00e9 – Rheumatology and Clinical Immunology<\/p>\n <\/div>\n <\/div>\n\n

\n

triantafyllopoulou@drfz.de<\/a><\/p>\n <\/div>\n Prof. Antigoni Triantafyllopoulou, MD<\/span><\/a>\n<\/article> <\/div>\n <\/div>\n <\/section>\n\n\n\n

Clusters of Excellence<\/h2>\n\n\n\n

Clusters of Excellence have been part of the Excellence Initiative since 2006 and promote outstanding research groups at German universities in internationally competitive fields. Each cluster can receive up to 10 million euros per year. The funding covers two periods of seven years each. Clusters of Excellence form one of the two pillars of the Excellence Strategy.<\/p>\n\n\n\n

\n
Exzellenzcluster (DFG)<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The DRFZ is part of the new Cluster of Excellence The German Rheumatology Research Center, a Leibniz Institute, is partner in the new Berlin Cluster\u2026<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[288,292],"tags":[442,407,403,441,410,413,492,497],"programme-area-tax":[],"working-group-tax":[253,245,250,246,239,254],"class_list":["post-17475","post","type-post","status-publish","format-standard","hentry","category-for-patients","category-news-en","tag-clinical-rheumatology","tag-developmental-mucosal-immunology","tag-immunobiology-of-inflammation","tag-inflammatory-mechanisms","tag-innate-immunity","tag-macrophages-in-chronic-inflammation","tag-program-area-1","tag-program-area-4","working-group-tax-clinical-rheumatology","working-group-tax-developmental-and-mucosal-immunology","working-group-tax-immunobiology-of-inflammation","working-group-tax-inflammatory-mechanisms","working-group-tax-innate-immunity","working-group-tax-macrophage-biology-and-innate-cellular-networks-in-chronic-inflammatory-diseases"],"acf":[],"yoast_head":"\nEarly recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research - DRFZ<\/title>\n<meta name=\"description\" content=\"The German Rheumatology Research Center Berlin, a Leibniz Institute, is a partner in the new Berlin Cluster of Excellence ImmunoPreCept.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research - DRFZ\" \/>\n<meta property=\"og:description\" content=\"The German Rheumatology Research Center Berlin, a Leibniz Institute, is a partner in the new Berlin Cluster of Excellence ImmunoPreCept.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/\" \/>\n<meta property=\"og:site_name\" content=\"DRFZ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/drfz.de\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-22T15:56:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-21T07:46:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/05\/Cluster-Projekt-Bekanntgabe_web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ute Hoffmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:site\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ute Hoffmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/\"},\"author\":{\"name\":\"Ute Hoffmann\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/a86dc60d63c6fa52cb3ee62f12c72737\"},\"headline\":\"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research\",\"datePublished\":\"2025-05-22T15:56:22+00:00\",\"dateModified\":\"2025-07-21T07:46:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/\"},\"wordCount\":334,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Cluster-Projekt-Bekanntgabe_web.jpg\",\"keywords\":[\"Clinical Rheumatology\",\"Developmental & Mucosal Immunology\",\"Immunobiology of Inflammation\",\"Inflammatory Mechanisms\",\"Innate Immunity\",\"Macrophages in Chronic Inflammation\",\"Program area 1\",\"Program area 4\"],\"articleSection\":[\"For patients\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/\",\"name\":\"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research - DRFZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Cluster-Projekt-Bekanntgabe_web.jpg\",\"datePublished\":\"2025-05-22T15:56:22+00:00\",\"dateModified\":\"2025-07-21T07:46:47+00:00\",\"description\":\"The German Rheumatology Research Center Berlin, a Leibniz Institute, is a partner in the new Berlin Cluster of Excellence ImmunoPreCept.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Cluster-Projekt-Bekanntgabe_web.jpg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Cluster-Projekt-Bekanntgabe_web.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"name\":\"DRFZ\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\",\"name\":\"Deutsches Rheuma-Forschungszentrum\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Deutsches Rheuma-Forschungszentrum\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/drfz.de\\\/\",\"https:\\\/\\\/x.com\\\/DRFZ_Berlin\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/deutsches-rheuma-forschungszentrum-berlin\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCf8nDuqpkWwcmCWmfSTkE3w\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/a86dc60d63c6fa52cb3ee62f12c72737\",\"name\":\"Ute Hoffmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"caption\":\"Ute Hoffmann\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research - DRFZ","description":"The German Rheumatology Research Center Berlin, a Leibniz Institute, is a partner in the new Berlin Cluster of Excellence ImmunoPreCept.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/","og_locale":"en_US","og_type":"article","og_title":"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research - DRFZ","og_description":"The German Rheumatology Research Center Berlin, a Leibniz Institute, is a partner in the new Berlin Cluster of Excellence ImmunoPreCept.","og_url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/","og_site_name":"DRFZ","article_publisher":"https:\/\/www.facebook.com\/drfz.de\/","article_published_time":"2025-05-22T15:56:22+00:00","article_modified_time":"2025-07-21T07:46:47+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/05\/Cluster-Projekt-Bekanntgabe_web.jpg","type":"image\/jpeg"}],"author":"Ute Hoffmann","twitter_card":"summary_large_image","twitter_creator":"@DRFZ_Berlin","twitter_site":"@DRFZ_Berlin","twitter_misc":{"Written by":"Ute Hoffmann","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/#article","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/"},"author":{"name":"Ute Hoffmann","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/a86dc60d63c6fa52cb3ee62f12c72737"},"headline":"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research","datePublished":"2025-05-22T15:56:22+00:00","dateModified":"2025-07-21T07:46:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/"},"wordCount":334,"publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/05\/Cluster-Projekt-Bekanntgabe_web.jpg","keywords":["Clinical Rheumatology","Developmental & Mucosal Immunology","Immunobiology of Inflammation","Inflammatory Mechanisms","Innate Immunity","Macrophages in Chronic Inflammation","Program area 1","Program area 4"],"articleSection":["For patients","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/","url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/","name":"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research - DRFZ","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/#primaryimage"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/05\/Cluster-Projekt-Bekanntgabe_web.jpg","datePublished":"2025-05-22T15:56:22+00:00","dateModified":"2025-07-21T07:46:47+00:00","description":"The German Rheumatology Research Center Berlin, a Leibniz Institute, is a partner in the new Berlin Cluster of Excellence ImmunoPreCept.","breadcrumb":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/#primaryimage","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/05\/Cluster-Projekt-Bekanntgabe_web.jpg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/05\/Cluster-Projekt-Bekanntgabe_web.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/early-recognition-targeted-intervention-staying-healthy-immunoprecept-unites-top-berlin-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drfz.de\/en\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.drfz.de\/en\/news\/"},{"@type":"ListItem","position":3,"name":"Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research"}]},{"@type":"WebSite","@id":"https:\/\/www.drfz.de\/en\/#website","url":"https:\/\/www.drfz.de\/en\/","name":"DRFZ","description":"","publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drfz.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.drfz.de\/en\/#organization","name":"Deutsches Rheuma-Forschungszentrum","url":"https:\/\/www.drfz.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","width":1,"height":1,"caption":"Deutsches Rheuma-Forschungszentrum"},"image":{"@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/drfz.de\/","https:\/\/x.com\/DRFZ_Berlin","https:\/\/www.linkedin.com\/company\/deutsches-rheuma-forschungszentrum-berlin","https:\/\/www.youtube.com\/channel\/UCf8nDuqpkWwcmCWmfSTkE3w"]},{"@type":"Person","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/a86dc60d63c6fa52cb3ee62f12c72737","name":"Ute Hoffmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","caption":"Ute Hoffmann"}}]}},"_links":{"self":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/17475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/comments?post=17475"}],"version-history":[{"count":11,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/17475\/revisions"}],"predecessor-version":[{"id":19094,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/17475\/revisions\/19094"}],"wp:attachment":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media?parent=17475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/categories?post=17475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/tags?post=17475"},{"taxonomy":"programme-area-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/programme-area-tax?post=17475"},{"taxonomy":"working-group-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/working-group-tax?post=17475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}